Calendar BioNTech SE

Equities

BNTX

US09075V1026

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
87.21 USD +0.58% Intraday chart for BioNTech SE +0.46% -17.37%

Chart calendar BioNTech SE

2.IDxWCeH18Y6sovu73pYYpc3XQixC6FnD1Q-MvtO2sAQ.THQfXqqAh_rNl4jztv1v46qULVQgtza5mED616P-21t3Xidevse9wO2Pww~835b4a9e67ddf5af3317ef52229a7ca8

Upcoming events on BioNTech SE

05/05/2024 Q1 2024 Earnings Release Pre-market
06/05/2024 13:00 Q1 2024 Earnings Call
17/05/2024 17:00 Annual General Meeting
04/08/2024 Q2 2024 Earnings Call
04/08/2024 Q2 2024 Earnings Release Pre-market
03/11/2024 Q3 2024 Earnings Call
03/11/2024 Q3 2024 Earnings Release Pre-market
31/03/2025 Q4 2024 Earnings Release (Projected)
11/05/2025 Q1 2025 Earnings Release (Projected)
10/08/2025 Q2 2025 Earnings Release (Projected)
09/11/2025 Q3 2025 Earnings Release (Projected)

Past events on BioNTech SE

07/04/2024 American Association for Cancer Research Meeting - Poster Number CT165
07/04/2024 American Association for Cancer Research Meeting - Poster Number CT051
07/04/2024 23:00 American Association for Cancer Research Meeting - Abstract No: CT025
20/03/2024 12:00 Q4 2023 Earnings Call
20/03/2024 10:15 Q4 2023 Earnings Release
10/03/2024 Leerink Partners Global Biopharma Conference
04/03/2024 19:10 TD Cowen Health Care Conference
26/02/2024 UBS European Healthcare Conference
12/02/2024 Oppenheimer Healthcare Life Sciences Conference
09/01/2024 17:00 JPMorgan Healthcare Conference
14/11/2023 14:30 Jefferies London Healthcare Conference
07/11/2023 14:00 Capital Markets Day - Innovation Series
06/11/2023 13:00 Q3 2023 Earnings Call
06/11/2023 11:45 Q3 2023 Earnings Release
03/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number : 769
03/11/2023 22:30 Society for Immunotherapy of Cancer Meeting - Abstract Number : 599
02/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number : 597
02/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number : 813
02/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number : 1181
23/10/2023 15:30 European Society for Medical Oncology Congress - Abstract No LBA35

Past dividends on BioNTech SE

01/06/2022 1.549832 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
109
110
-1.61%
482
432
11.66%
18 977
17 212
10.25%
17 311
16 583
4.39%
3 819
4 188
-8.8%

2 796

EBITDA
Million EUR
Released
Forecast
Spread
-148
-145
-1.86%
-43,7
-287
84.76%
15 359
13 568
13.2%
12 766
12 149
5.08%
874
986
-11.36%

-640

EBIT
Million EUR
Released
Forecast
Spread
-182
-167
-8.67%
-82,4
-306
73.08%
15 284
13 364
14.37%
12 643
11 959
5.72%
690
866
-20.31%

-872

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-179
-158
-13.91%
-146
-325
55.09%
15 046
13 109
14.78%
12 954
12 372
4.7%
1 186
1 270
-6.57%

-727

Net income
Million EUR
Released
Forecast
Spread
-179
-157
-14.39%
15,2
-336
104.53%
10 293
9 140
12.6%
9 434
8 838
6.75%
930
1 070
-13.05%

-552

EPS
EUR
Released
Forecast
Spread
-0,85
-0,74
-14.97%
0,06
-1,44
104.17%
39,6
36,2
9.36%
37,8
35,2
7.41%
3,83
4,45
-13.99%

-2,29

Announcement Date31/03/2030/03/2130/03/2227/03/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million EUR
Released
Forecast
Spread
5 533
3 918
41.19%
6 375
4 496
41.77%
3 197
4 109
-22.2%
3 461
1 903
81.91%
4 278
3 863
10.75%
1 277
1 092
16.92%
168
714
-76.53%
895
775
15.45%
1 479
1 850
-20.04%

453


158


705


1 464


97,2

EBITDA
Million EUR
Released
Forecast
Spread
4 726
2 750
71.84%






2 421
1 184
104.48%
3 322
3 297
0.76%
686
-160
528.63%



114
-294
138.96%
605
602
0.5%

-585


-660


-290


824




EBIT
Million EUR
Released
Forecast
Spread
4 700
2 817
66.86%
4 753
3 449
37.79%
2 210
2 848
-22.42%
2 388
1 295
84.34%
3 293
2 543
29.5%
654
226
189.21%
-563
-42,6
-1221.19%
73,1
10,6
586.84%
526
699
-24.69%

-374


-637


-246


295


-804

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
4 714
2 475
90.43%
5 018
3 337
50.39%
2 319
2 892
-19.82%
2 444
1 426
71.38%
3 173
2 658
19.38%
708
200
253.56%
-412
378
-208.99%
227
374
-39.15%
663
773
-14.19%

-290


-575


-193


428




Net income
Million EUR
Released
Forecast
Spread
3 166
1 893
67.22%
3 699
2 484
48.92%
1 672
2 056
-18.66%
1 785
930
91.99%
2 279
1 931
17.98%
502
110
357.58%
-190
-3,99
-4675.04%
161
-19,4
926.25%
458
619
-26.07%

-264


-527


-178


398




EPS
EUR
Released
Forecast
Spread
12,2
7,55
61.33%
14,2
8,90
60.05%
6,45
7,57
-14.81%
6,98
4,86
43.48%
9,26
8,07
14.75%
2,05
0,57
258.03%
-0,79
-0,39
-102.27%
0,67
-0,19
459.35%
1,90
2,65
-28.18%

-1,20


-1,92


-0,68


1,33


-1,50

Announcement Date30/03/2209/05/2208/08/2207/11/2227/03/2308/05/2307/08/2306/11/2320/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise